Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedSep 26, 2018MethylPREDNISolone TabletsFailed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.Jubilant Cadista Pharmaceuticals, Inc. · D-1205-2018Class IITerminatedSep 26, 2018Lamotrigine Extended-Release TabletsFailed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.Torrent Pharma Inc. · D-1204-2018Class IITerminatedSep 26, 2018Arthritis Pain Relief Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1199-2018Class IITerminatedSep 26, 2018Colds & Flu Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1198-2018Class IITerminatedSep 26, 2018Allergy & Hay Fever Relief Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1197-2018Class IITerminatedSep 26, 2018Muscle & Joint Pain Relief Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1196-2018Class IITerminatedSep 26, 2018Diarrhea Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1195-2018Class IITerminatedSep 26, 2018Sore Throat & Laryngitis Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1194-2018Class IITerminatedSep 26, 2018Sinus Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1193-2018Class IITerminatedSep 26, 2018Skin Irritation & Itch Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1192-2018Class IITerminatedSep 26, 2018Tizanidine HCl TabletsPresence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .Dr. Reddy's Laboratories, Inc. · D-1191-2018Class IITerminatedSep 26, 20180.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation DeerfieldcGMP DeviationBaxter Healthcare Corporation · D-1190-2018Class ITerminatedSep 26, 2018Norepinephrine 4 mgSubpotent Drug: Product may not have the active ingredient present in the bag.QuVa Pharma, Inc. · D-0003-2019Class ITerminatedSep 19, 2018Hydrochlorothiazide Tablets USPProduct Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.Accord Healthcare, Inc. · D-1206-2018Class ITerminatedSep 19, 2018RespitrolMicrobial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia...Hellolife · D-1203-2018Class ITerminatedSep 19, 2018ThyroveevMicrobial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia...Hellolife · D-1202-2018Class ITerminatedSep 19, 2018NeuroveenMicrobial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia...Hellolife · D-1201-2018Class ITerminatedSep 19, 2018CompulsinMicrobial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia...Hellolife · D-1200-2018Class ITerminatedSep 19, 2018Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL InjectionPresence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.SCA Pharmaceuticals, Inc. · D-1189-2018Class IIITerminatedSep 19, 2018Tyvaso Inhalation System Patient a) Starter Kit with TYVASODefective Delivery System: Water ingress through the lower water cup sensor of the device.United Therapeutics Corp. · D-1188-2018Class IIITerminatedSep 19, 2018Diltiazem HCl Extended-Release CapsulesFailed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.Mylan Pharmaceuticals Inc. · D-1187-2018Class IIITerminatedSep 19, 2018Diltiazem HCl Extended-Release CapsulesFailed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.Mylan Pharmaceuticals Inc. · D-1186-2018Class IIITerminatedSep 19, 2018Pramipexole dihydrochloride extended release tabletsFailed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.Par Pharmaceutical, Inc. · D-1185-2018Class IIITerminatedSep 19, 2018Argatroban InjectionFailed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time pointPfizer Inc. · D-1184-2018Class IITerminatedSep 12, 2018Ethosuximide CapsulesFailed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.Akorn, Inc. · D-1183-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 320 mg/25 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1177-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1176-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 160 mg/25 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1175-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 160 mg/12.5 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1174-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 80 mg/12.5 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1173-2018Class IITerminatedSep 12, 2018Megestrol Acetate Oral SuspensionSupterpotent DrugMckesson Corporation · D-1172-2018Class IIITerminatedSep 5, 2018RocaltrolSubpotency: lower than expected potency result was obtained at the 18 month stability time point.Validus Pharmaceuticals, Inc. · D-1171-2018Class IIITerminatedSep 5, 2018Calcitriol Oral SolutionSubpotency: lower than expected potency result was obtained at the 18 month stability time point.Validus Pharmaceuticals, Inc. · D-1170-2018Class IITerminatedSep 5, 2018Children s Advil Suspension Ibuprofen Oral SuspensionLabeling Error: Not elsewhere classified. product has a dosage cup marked in teaspoons and the instructions on the label are described in milliliters.Pfizer Global Supply · D-1169-2018Class IIITerminatedSep 5, 2018Azelastine HCl Ophthalmic Solution 0.05%Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxideAkorn, Inc. · D-1168-2018Class IITerminatedSep 5, 2018Methyl-Cobalamin injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1167-2018Class IITerminatedSep 5, 2018Folic Acid injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1166-2018Class IITerminatedSep 5, 2018Testosterone Enanthate/Cypionate injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1165-2018Class IITerminatedSep 5, 2018Testosterone Cypionate/Enanthate injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1164-2018Class IITerminatedSep 5, 2018Testosterone Cypionate/Enanthate injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1163-2018